-
Kitsap Respiratory Illness Report: Week 17 (4/20/2025 – 4/26/2025)
In week ending April 26, local indicators for influenza were low and continued to approach baseline levels, while indicators for COVID-19 and respiratory syncytial virus (RSV) remained minimal. Other Puget Sound counties observed similar trends. Regional laboratory surveillance most frequently detected rhinovirus among clinical respiratory specimens, followed by SARS-CoV-2 (COVID-19). Fewer than 10 emergency department (ED) visits were attributable to…
-
Health Advisory: COVID-19 Updates for Providers
Advisory or Update, Communicable Disease and Immunization Update, COVID-19, Emerging Diseases and Conditions, Health Advisory, Health Alert, Immunizations, News and Alerts, Notifiable Conditions, Novel Coronavirus, Provider Resources, VaccineActions Requested Be aware, on March 4, the WA Dept. of Health (DOH) discontinued ordering of the Johnson & Johnson (Janssen) COVID-19 vaccine due to extremely limited inventory at the Centers for Disease Control and Prevention (CDC) in the Washington Immunization Information System (IIS). Providers are encouraged to post and look for excess doses in…
-
03/07/22 Health Advisory: Update on Johnson & Johnson vaccine ordering and guidance for healthcare settings
Advisory or Update, COVID-19, Health Advisory, Immunizations, News and Alerts, Notifiable Conditions, Provider ResourcesRequested actions Be aware, on March 4, Washington State Department of Health (DOH) discontinued ordering Johnson & Johnson COVID-19 vaccine because inventory is very low at Centers for Disease Control and Prevention (CDC) in Washington Immunization Information System (IIS). We encourage providers to post and look for available doses on IIS vaccine advertisement page. Email…
-
Kitsap Respiratory Illness Report: February 20 – February 26, 2022
Click here to access the latest Kitsap Respiratory Illness Report: 2.20.22 – 2.26.22
-
Health Advisory: COVID-19 Updates for Providers
Advisory or Update, Communicable Disease and Immunization Update, COVID-19, Health Advisory, Health Alert, News and Alerts, News and Update, Notifiable Conditions, Novel Coronavirus, Provider Resources, SchoolsActions Requested Be aware, on Feb. 22, Centers for Disease Control and Prevention (CDC) revised its COVID-19 vaccine clinical considerations. An 8-week interval between first and second doses of mRNA COVID-19 vaccine (Moderna and Pfizer) may be optimal for males 12–39 years old to reduce risk of myocarditis and increase efficacy. CDC still recommends a…
-
02/25/22 Health Advisory: COVID-19 Updates for Providers
Requested actions Be aware, on Feb. 22, Centers for Disease Control and Prevention (CDC) revised its COVID-19 vaccine clinical considerations. An 8-week interval between first and second doses of mRNA COVID-19 vaccine (Moderna and Pfizer) may be optimal for males 12–39 years old to reduce risk of myocarditis and increase efficacy. CDC still recommends a…
-
Kitsap Respiratory Illness Report: February 13 – February 19, 2022
Click here to access the latest Kitsap Respiratory Illness Report: 2.13.22 – 2.19-22
-
Kitsap Respiratory Illness Report February 6 – February 12, 2022
Click here to access the latest Kitsap Respiratory Illness Report: 2.6.22 – 2.12.22.
-
Health Advisory: COVID-19 Updates for Providers
Advisory or Update, Communicable Disease and Immunization Update, COVID-19, Emerging Diseases and Conditions, Health Alert, Immunization, Immunizations, News and Alerts, News and Update, Notifiable Conditions, Novel Coronavirus, Provider Resources, VaccineActions Requested Be aware, on February 11, the Centers for Disease Control and Prevention updated their guidance for COVID-19 vaccination to include: People who are moderately or severely immunocompromised should: Complete their primary series of 2 mRNA (Pfizer-BioNTech or Moderna) doses, a third dose at least 28 days after the initial two-dose series and an mRNA…
-
Kitsap Respiratory Illness Report January 30 – February 5, 2022
Click here to access the latest Kitsap Respiratory Illness Report: 1.30.22 – 2.5.22.
-
02/14/22 Health Advisory: CDC Updated Covid-19 Vaccination Guidelines; FDA Postponed its pediatric Covid-19 Vaccination Review
COVID-19 Updates for Providers Requested actions Be aware, on February 11, the Centers for Disease Control and Prevention updated their guidance for COVID-19 vaccination to include: For people who are moderately or severely immunocompromised: People who have completed a primary series of an mRNA vaccine (Pfizer-BioNTech or Moderna) are recommended to receive an mRNA booster…
-
Health Advisory: COVID-19 Updates
Advisory or Update, Communicable Disease and Immunization Update, COVID-19, Emerging Diseases and Conditions, Health Advisory, Health Alert, Immunizations, News and Alerts, Notifiable Conditions, Novel Coronavirus, Provider Resources, VaccineActions Requested Discuss a fourth dose of COVID-19 vaccine with immunocompromised patients. The Centers for Disease Control and Prevention (CDC) recommends people ages 5 and older who are moderately or severely immunocompromised should get an additional primary shot (third dose) of an mRNA vaccine 28 days after receiving their second dose. An additional primary shot…
-
Kitsap Respiratory Illness Report January 23 – January 29, 2022
Click here to access the latest Kitsap Respiratory Illness Report: 1.23.22 – 1.29.22.